Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
基本信息
- 批准号:9043453
- 负责人:
- 金额:$ 1.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:10 year old5 year oldAdolescentAdultAffectAgeAllelesAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAppearanceArginineBiological AssayBiological MarkersBirthBloodCaucasiansCell physiologyCellsChildChloride ChannelsClinicalClinical ResearchComorbidityComplicationCoupledCyclooxygenase InhibitorsCystic FibrosisDataDefectDevelopmentDiabetes MellitusDiseaseDoseDoxycyclineDuctal Epithelial CellEarly DiagnosisEarly InterventionEarly treatmentEndocrineEuglycemic ClampingEventExocrine pancreasFamily suidaeFerretsFunctional disorderGallbladderGlucoseGlucose ClampGlucose IntoleranceGoalsHealthHepaticHereditary DiseaseHormonalHormonesHumanHyperglycemiaHypoglycemiaIbuprofenImageImpairmentIn VitroIncidenceInflammationInflammation MediatorsInflammatoryInsulinInterleukin-6IntestinesIslet CellIslets of LangerhansLeadLifeLiverLungMediatingMessenger RNAMethodsMicroRNAsModelingMonoclonal Antibody R24Morbidity - disease rateNeonatalNewborn InfantNutritionalOGTTOrganPET/CT scanPancreasPathogenesisPathologyPathway interactionsPeripheralPhasePhysiologyPlayPopulationPreventionProcessRecoveryRegulationResearchRespiratory physiologyRoleSalicylic AcidsSecondary toTestingToddlerWorkage relatedautocrinecell typechildren with cystic fibrosisclinical Diagnosisclinical carecohortcystic fibrosis patientsdefined contributiondiabetes riskearly cystic fibrosisfluorodeoxyglucoseglucose disposalglucose productionglucose tolerancehigh riskhormone regulationimpaired glucose toleranceimprovedin vivoinsulin secretioninsulin sensitivityisletmortalityparacrinepreventsingle moleculesmall hairpin RNAstellate celltype I and type II diabetesvector
项目摘要
DESCRIPTION (provided by applicant): Cystic Fibrosis (CF) is the most common lethal genetic disorder in Caucasian populations and is caused by defects in the cystic fibrosis conductance regulator (CFTR) chloride channel. CF is a multi-organ disease affecting the lung, pancreas, liver, intestine, and gallbladder. Cystic fibrosis related diabetes (CFRD) is the most common significant complication of CF and is associated with increased morbidity and mortality. CFRD, which is pathophysiologically distinct from type 1 and type 2 diabetes, significantly worsens the nutritional and pulmonary health of CF patients. Glycemic abnormalities are common in children with CF, and the 13% of CF children 6-10 years of age that have abnormal glycemic status are at extraordinarily high risk for developing diabetes within the next few years.
Our studies in CF ferrets and children 3 months to 5 years of age suggest that the underpinnings of CFRD occur very early in life. Of 12 CF subjects who were 1-5 years of age and have at least one ?F508 allele, 42% demonstrated abnormal glucose tolerance. This high incidence of abnormal glucose tolerance in young CF children as compared to slightly older children (13% at 6-10 years of age) is consistent with our discovery that in CF ferrets glucose intolerance develops in phases (with intervening periods of temporary recovery) that are associated with changes in the regulation of insular axis hormones and fibrotic remodeling of the pancreas. A major goal of this R24 is to identify the early pathophysiologic events involved in CF pancreas remodeling and the development of CFRD. The observed disturbances in insular and entero-insular axis hormones in young CF children are consistent with the hypothesis that both positive and negative adaptive changes influence insulin regulation, and potentially insulin action. Similar age-dependent alterations occur in CF ferrets and will enable us to dissect the mechanisms that underlie these processes. Studies in isolated human, ferret, and pig islets have demonstrated that CFTR impacts glucose-stimulated insulin secretion by islets through its activity in either endocrine cells or islet-associated ductal cells. The propose research will identify pancreas-intrinsic and -extrinsic events that alter insulin secretion and glycemic status in CF, with a focus on defining (i) the islet-intrinsic mechanisms that control CFTR-dependent insulin secretion in vitro and in vivo, (ii) the pancreas-extrinsic mechanisms that lead to abnormal insulin secretion and altered glucose physiology in CF, and (iii) the extent to which endocrine pancreas remodeling contributes to subsequent abnormalities in insulin secretion, and whether amelioration of the primary wave of pancreas inflammation in CF can prevent maladaptive islet remodeling. These studies are expected to identify early blood biomarkers of CFRD risk, as well as methods for early intervention.
描述(由申请人提供):囊性纤维化(CF)是高加索人群中最常见的致命遗传疾病,是由囊性纤维化电导调节剂(CFTR)氯化物通道缺陷引起的。 CF是一种多器官疾病,影响肺,胰腺,肝脏,肠和胆囊。囊性纤维化相关糖尿病(CFRD)是CF的最常见并发症,与发病率和死亡率的增加有关。 CFRD在病理生理上与1型和2型糖尿病不同,它显着恶化了CF患者的营养和肺部健康。血糖异常在CF儿童中很常见,在6-10岁的CF儿童中,具有异常血糖状况的儿童在未来几年内患糖尿病的患者具有异常高的风险。
我们在CF雪貂和儿童3个月至5岁的研究中的研究表明,CFRD的基础是生命早期。在1-5岁的12名CF受试者中,至少有1个f508等位基因,有42%的受试者表现出异常的葡萄糖耐受性。与稍大的儿童相比,年轻CF儿童的葡萄糖耐量异常(6-10岁)与我们的发现一致,我们发现,在CF雪貂中,葡萄糖不耐症在阶段(临时恢复的临时恢复)与Insular轴心激素和纤维纤维纤维的变化相关。该R24的主要目标是确定CF胰腺重塑和CFRD发展中涉及的早期病理生理事件。在年轻CF儿童中观察到的岛和肠道轴激素中观察到的干扰与假设阳性和阴性自适应变化都会影响胰岛素调节以及潜在的胰岛素作用的假设一致。在CF雪貂中发生了类似的年龄依赖性改变,将使我们能够剖析这些过程的基础。对分离的人,雪貂和猪胰岛进行的研究表明,CFTR通过胰岛在内分泌细胞或与胰岛相关的导管细胞中的活性影响葡萄糖刺激的胰岛素分泌。提出的研究将确定CF中胰岛素分泌和血糖状态的胰腺内膜和 - 超支事件,重点是定义(i)控制CFTR依赖性胰岛素的体外和体外和体内的胰岛胰岛素分泌的胰岛内部机制,这些机制的体外和胰腺源性机制,(ii)unin sectim in Instormist in Instormistion in Instormist in Instormist in Instormistion in Instormist in Instormistion Instormist in Instormistion in Instormistion in Instormist in Instormistion in Instormistion in Instormistim CF,以及(iii)内分泌胰腺重塑的程度有助于随后的胰岛素分泌异常,以及CF主要胰腺炎症的主要波动是否可以防止疾病疾病的胰岛重塑。预计这些研究将确定CFRD风险的早期血液生物标志物以及早期干预的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN F ENGELHARDT其他文献
JOHN F ENGELHARDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN F ENGELHARDT', 18)}}的其他基金
Biology of Submucosal Gland Stem Cells in the Airway
气道粘膜下腺干细胞的生物学
- 批准号:
10516449 - 财政年份:2022
- 资助金额:
$ 1.36万 - 项目类别:
National Ferret Research and Resource Institute (NFRRI) at University of Iowa
爱荷华大学国家雪貂研究与资源研究所 (NFRRI)
- 批准号:
10596901 - 财政年份:2022
- 资助金额:
$ 1.36万 - 项目类别:
Biology of Submucosal Gland Stem Cells in the Airway
气道粘膜下腺干细胞的生物学
- 批准号:
10649543 - 财政年份:2022
- 资助金额:
$ 1.36万 - 项目类别:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
- 批准号:
10599931 - 财政年份:2021
- 资助金额:
$ 1.36万 - 项目类别:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
- 批准号:
10397094 - 财政年份:2021
- 资助金额:
$ 1.36万 - 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
- 批准号:
10470338 - 财政年份:2020
- 资助金额:
$ 1.36万 - 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
- 批准号:
10677622 - 财政年份:2020
- 资助金额:
$ 1.36万 - 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
- 批准号:
10248531 - 财政年份:2020
- 资助金额:
$ 1.36万 - 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
- 批准号:
10024668 - 财政年份:2020
- 资助金额:
$ 1.36万 - 项目类别:
National Ferret Resource and Research Center on Lung Disease
国家雪貂资源与肺部疾病研究中心
- 批准号:
8751112 - 财政年份:2014
- 资助金额:
$ 1.36万 - 项目类别:
相似国自然基金
内蒙古自治区5岁以下儿童死亡状况研究
- 批准号:81760591
- 批准年份:2017
- 资助金额:11.0 万元
- 项目类别:地区科学基金项目
基于LiST模型的西藏自治区孕产妇和儿童健康干预效果预测及策略研究
- 批准号:71603007
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
3-5岁幼儿说谎行为的发展及其影响因素的追踪研究
- 批准号:31400892
- 批准年份:2014
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
云南省汉族和彝族50岁以上人群原发性青光眼5年随访研究
- 批准号:81371016
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
5-6岁儿童被动吸烟随机对照干预研究
- 批准号:81273089
- 批准年份:2012
- 资助金额:65.0 万元
- 项目类别:面上项目
相似海外基金
Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
- 批准号:
8769764 - 财政年份:2012
- 资助金额:
$ 1.36万 - 项目类别:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
- 批准号:
9110992 - 财政年份:2012
- 资助金额:
$ 1.36万 - 项目类别:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
- 批准号:
9312250 - 财政年份:2012
- 资助金额:
$ 1.36万 - 项目类别:
Combined Peanut Oral Immunotherapy and Anti-IgE: Mechanistic Studies
花生口服免疫疗法与抗 IgE 联合治疗:机制研究
- 批准号:
8094570 - 财政年份:2011
- 资助金额:
$ 1.36万 - 项目类别:
Combined Peanut Oral Immunotherapy and Anti-IgE: Mechanistic Studies
花生口服免疫疗法与抗 IgE 联合治疗:机制研究
- 批准号:
8320084 - 财政年份:2011
- 资助金额:
$ 1.36万 - 项目类别: